Abstract
Many different IV iron preparations are available worldwide, and these differ in their physicochemical characteristics, biologic actions, and quantity of iron able to be administered at a single sitting. Some of the older IV iron preparations (iron sucrose, iron gluconate) exhibit a more rapid release of iron from the iron-carbohydrate complex, limiting the rate and dose of iron administered. This is not a problem in patients receiving maintenance hemodialysis who have ready vascular access, and are attending a dialysis center several times a week. However, patients not receiving dialysis are usually better off receiving one of the newer IV iron preparations (ferric carboxymaltose, ferumoxytol, or iron isomaltoside 1000), which allow for a larger dose of iron to be administered over a relatively short period of time, at a single sitting.

This publication has 11 references indexed in Scilit: